Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)

81.79
BATS BZX Real-Time Price
As of 1:42pm ET
 +4.32 / +5.58%
Today’s Change
46.52
Today|||52-Week Range
86.77
+16.33%
Year-to-Date

Today’s Trading

Previous close77.47
Today’s open78.34
Day’s range77.70 - 81.93
Volume10,273
Average volume (3 months)536,200
Market cap$3.2B
Dividend yield--
Data as of 1:42pm ET, 02/27/2017

Growth & Valuation

Earnings growth (last year)-56.82%
Earnings growth (this year)-14.84%
Earnings growth (next 5 years)+15.49%
Revenue growth (last year)--
P/E ratioNM
Price/Sales20,927.50
Price/Book6.74

Competitors

 Today’s
change
Today’s
% change
GLPGGalapagos NV+0.63+0.91%
GWPHGW Pharmaceuticals P...+0.17+0.14%
PBHPrestige Brands Hold...+0.20+0.35%
CBPOChina Biologic Produ...-1.46-1.34%
Data as of 1:28pm ET, 02/27/2017

Financials

Next reporting dateMay 15, 2017
EPS forecast (this quarter)-$1.72
Annual revenue (last year)$133.0K
Annual profit (last year)-$245.9M
Net profit margin-184,867.67%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Emil D. Kakkis
CFO, Senior VP &
Head-Investor Relations
Shalini Sharp
Corporate headquarters
Novato, California

Forecasts


Search for Jobs